AOD 9604

AOD-9604 is a synthetic peptide derived from a modified fragment of human growth hormone (hGH), corresponding to the hGH 176-191 region and containing a disulfide bridge. This hexadecapeptide is investigated in laboratory and early clinical research for its activity on lipid metabolism-associated signaling pathways. AOD-9604 research evaluates how this specific C-terminal fragment influences adipocyte biology, fatty-acid mobilization, and metabolic pathway regulation under controlled experimental conditions, without replicating the full spectrum of hGH endocrine activity.

In vitro experiments and animal models assess endpoints including lipolytic activity, lipogenesis markers, adipocyte differentiation parameters, enzyme expression associated with lipid metabolism, and transcriptional changes related to energy balance. Preclinical systems frequently examine adipose tissue metabolism and nutrient-handling models to generate quantifiable biochemical and molecular readouts.